Trialect

Active

Introduction to the Clinical Neuropsychology of Major Depression & Schizophrenia- Accredited by The British Psychological Society

Brain Matters Institute and UCL

Brain Matters institute and UCL

Main Areas of Interest

Title: Introduction to the Clinical Neuropsychology of Major Depression & Schizophrenia - Accredited by The British Psychological Society.

Faculty: Dr Alexandra Pentaraki BA, MSc, PhD, CPsychol, AFBPsS

Clinical Psychologist & Neuropsychologist for children and adults-Lecturer-Registered Expert Witness in European Courts & in The International Criminal Court, The Hague

Hon. Lecturer, Applied Psychology & Mental Health, University of Liverpool (Online), UK (2012-2017) & Faculty, Psychology Department, University of Essex (Online), UK, (2018-2019); Faculty, New School of Counselling & Psychotherapy (NSCP)-Middlesex University, (2019-present)

Visiting Research Associate and Alumna, IoPPN, King's College London

Mode: e-mail, Skype

Lecturing and Teaching: The present workshop aims to inform mental health professionals and provide specialized knowledge in the neuropsychology of major depression and schizophrenia which will assist them in their clinical practice and research. This clinical workshop is designed for psychologists, neuropsychologists, psychiatrists, psychotherapists, social workers, GPs, occupational therapists, nurses, neuroscientists

Techniques You Will Learn

Education Credits: Approved by the British Psychological Society Learning Centre for the purposes of Continuing Professional Development (CPD). All participants will receive a Certificate of Attendance if they participate fully in the workshop and CPD credits by The British Psychological Society. The clinical workshop is organized and taught by Dr. Alexandra Pentaraki, PhD, CPsychol, AFBPsS.

Learning Outcomes:

Major Depression

Understand cognitive function in major depression
Review the research evidence of the neuropsychology of major depression
The assessment of neurocognitive function in major depression
Neurocognitive and therapeutic interventions in major depression

Schizophrenia

Understand the course of cognitive function and cognitive decline in schizophrenia
Review the research evidence of the neuropsychology of schizophrenia and its importance for clinical practice
The relationship between cognitive dysfunction (i.e. attention, verbal memory) and clinical symptoms in schizophrenia
The assessment of IQ, memory, attention, and executive function, psychomotor speed in schizophrenia (how do we select particular neuropsychological measurements in order to evaluation cognitive function in schizophrenia?)
Neuropsychological management of schizophrenia

Learning and Teaching Resources:

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub.

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: American Psychiatric Association.

Frith, D. C. (1992). The cognitive neuropsychology of schizophrenia. East Sussex, UK: Lawrence Erlbaum Associates.

Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia Bulletin, 26 (1), 119-136.

Green, M. F. (2001). Schizophrenia revealed: From neurons to social interactions. New York: Norton.

Lezak, D. M., Howieson, B. D., Loring, W. D., Hannay, H. J., & Fischer, J. S. (2004) (4th ed.). Neuropsychological assessment. Oxford: Oxford University Press.

Laws, K. R. (1999). A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: general intellectual deficit in disguise? Cognitive Neuropsychiatry, 4 (1), 1-30.

Laws, K.R., Al-Uzri, M., & Mortimer, A.M. (2000). Lexical degradation in schizophrenia. Schizophrenia Research, 45, 123-131.

Pentaraki, D. A. (2017). Theory of Mind and Mental Health: What the Evidence Suggests so Far? In Pentaraki, A. (Ed). Theory of Mind and Mental Health. IL: Bentham Science Publishers, (pp. 74-81).

Pentaraki, D.A., N.C.Stefanis, D. Stahl, C. Theleritis, T. Toulopoulou, D.Roukas, S.C.Kaliora, I.Chatzimanolis, N.Smyrnis, T.Russell, E.Kravariti, R.M.Murray. (2012). Theory of Mind as a potential endophenotype of schizophrenia-A family study. Cognitive Neuropsychiatry, 17 (1), 64-89.

Pentaraki, D.A. (2018). Treatment outcomes in depression: Increasing client’s engagement with cognitive therapy. BJPsych Advances, 24 (2), 101-109.

Modules

Tasks and Timeline:

Module 1 (week 1) Introduction to the diagnostic criteria for Major Depression and Schizophrenia and differential diagnosis. The course of neurocognitive deficits in schizophrenia. The role of General Intelligence (IQ) and its relationship with neurocognitive impairment in schizophrenia.

Module 2 (week 2) Depression in schizophrenia and its assessment. Introduction to the clinical neuropsychology of schizophrenia. Neurocognitive function in major depression.

Module 3 & Module 4 (week 3 & week 4) The relationship between cognitive dysfunction and the symptoms of schizophrenia. Introduction to the neuropsychological evaluation of schizophrenia ΙΙ. Introduction to the neuropsychological evaluation of major depression. In this week and in week 4 the students are asked to start their clinical practice either with real patients or with case studies. Their clinical practice involves the study of specific neuropsychological and psychometric tests, the assessment of patients/or the use of case studies that are derived from real patients, the scoring and interpretation of the assessments and a short report writing.

Module 5 (week 5) Cognitive remediation in schizophrenia. Neuropsychological techniques for the management of schizophrenia. The technique of normalization in the management of schizophrenia. The effect of Expressed Emotion on the prevention of relapse. Neurocognitive interventions in major depression. The effect of expressed emotion on the prevention of relapse. Interventions-Cognitive therapy andMindfulness in the management and prevention of relapse in major depression.

Assignments: Each week the students need to write up short assignments that involve the study of research papers and the writing up of summaries. There are also other exercises that the students need to complete.

Exam: At the end of week IV they will have to answer a short MCQ on the learning material.

Program Fee


Total Number of Modules
Time duration of Each module	minutes
Total Program Cost	$0

This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.

Who Can Apply

All are eligible

Host Details

Host Name: Dr. Alexandra Pentaraki

Affiliation: Brain Matters Institute and UCL

Address: Brain Matters Institute, GREECE and also affiliated to UCL

Website URL: https://scholar.google.com/citations?user=3FerdrYAAAAJ&hl=en

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.